CU23618A3 - NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS - Google Patents

NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Info

Publication number
CU23618A3
CU23618A3 CU20070049A CU20070049A CU23618A3 CU 23618 A3 CU23618 A3 CU 23618A3 CU 20070049 A CU20070049 A CU 20070049A CU 20070049 A CU20070049 A CU 20070049A CU 23618 A3 CU23618 A3 CU 23618A3
Authority
CU
Cuba
Prior art keywords
pharmaceutical compositions
treatment
new pharmaceutical
phenoxi
trifluorometil
Prior art date
Application number
CU20070049A
Other languages
Spanish (es)
Inventor
Paul Ehrlich
Susanne Zuleger
Jackes Dumas
Original Assignee
Bayer Pharmaceuticals Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corporation filed Critical Bayer Pharmaceuticals Corporation
Priority to CU20070049A priority Critical patent/CU23618A3/en
Publication of CU23618A3 publication Critical patent/CU23618A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESPACIO PARA FÓRMULA La invención se relaciona con nuevas composiciones farmacéuticas que comprenden una dispersión sólida del compuesto de la fórmula (I), procesos para preparar estas nuevas composiciones farmacéuticas y su uso en el tratamiento de trastornos hiperproliferativos, tal como cáncer, ya sea como único agente o en combinación con otras terapias.FORMULA SPACE The invention relates to new pharmaceutical compositions comprising a solid dispersion of the compound of the formula (I), processes for preparing these new pharmaceutical compositions and their use in the treatment of hyperproliferative disorders, such as cancer, either as single agent or in combination with other therapies.

CU20070049A 2007-02-27 2007-02-27 NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS CU23618A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20070049A CU23618A3 (en) 2007-02-27 2007-02-27 NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20070049A CU23618A3 (en) 2007-02-27 2007-02-27 NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Publications (1)

Publication Number Publication Date
CU23618A3 true CU23618A3 (en) 2011-01-27

Family

ID=43567373

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20070049A CU23618A3 (en) 2007-02-27 2007-02-27 NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORINE-3- TRIFLUOROMETIL-PHENYL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Country Status (1)

Country Link
CU (1) CU23618A3 (en)

Similar Documents

Publication Publication Date Title
ECSP077299A (en) NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORO-3-TRIFLUOROMETIL-FENIL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
UY31080A1 (en) PIRAZOL DERIVATIVES REPLACED WITH HETEROARILE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
NI201900041A (en) 1, 2, 4-TRIAZOLONES 2, 4, 5-TRISUSTITUIDAS
CL2017000287A1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines.
UY33598A (en) IMIDAZOPIRIDAZINAS REPLACED
MX2013004491A (en) Boronates as arginase inhibitors.
CL2007001869A1 (en) COMPOUNDS DERIVED FROM BENCIMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITIONS; AND USE FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES MODULATED WITH FXR AGONISTS, SUCH AS DISLIPIDEMIAS, DIABETES, CANCER, OSTEOPOROSIS AND E
CR11802A (en) DERIVATIVES OF INDAZOLS REPLACED WITH PHENYLL OR PIRIDINYL
UA110943C2 (en) N-ACYLSULPHONAMIDE PROMOTERS OF APOPTOSIS
UY35040A (en) PIRROLOPIRIMIDINILAMINO-BENZOTIAZOLONAS REPLACED
BR112012016797A2 (en) low dynamic intensifier using built-in equalizer compressor
EA201691590A1 (en) BENZIMIDAZOL-2-AMINES AS MIDHI INHIBITORS
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2015000942A1 (en) Compounds of substituted benzene.
EA201400311A1 (en) АМИНОЗАМЕЩЕННЫЕ ИМИДАЗОПИРИДАЗИНЫ
MX339201B (en) Sulphonamide compounds and methods of making and using same.
BR112014000792A2 (en) Piperidinyl Compounds for Use as Tanquirase Inhibitors
CO6470899A2 (en) 2,4-DIAMINOPIRIMIDINES FOR THE TREATMENT OF CHARACTERIZED DISEASES BY EXCESSIVE OR NORMAL CELL PROLIFERATION
CO6640327A2 (en) Pyrazole compounds as sigma receptor inhibitors
DOP2016000253A (en) NEW COMPOUNDS
BR112014011254A2 (en) 2-thiopyrimidinones
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS
CL2011002617A1 (en) Compounds derived from 2,5-disubstituted arylsulfonamides, ccr3 receptor modulators; pharmaceutical composition that includes them; and use of the compound or composition to prevent and / or treat an inflammatory or immunoregulatory disorder such as asthma, rhinitis, hiv, Alzheimer's disease, among others.
SV2017005466A (en) PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2

Legal Events

Date Code Title Description
FG Grant of patent